BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17068635)

  • 1. Peroxynitrite can affect platelet responses by inhibiting energy production.
    Rusak T; Tomasiak M; Ciborowski M
    Acta Biochim Pol; 2006; 53(4):769-76. PubMed ID: 17068635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide and platelet energy metabolism.
    Tomasiak M; Stelmach H; Rusak T; Wysocka J
    Acta Biochim Pol; 2004; 51(3):789-803. PubMed ID: 15448739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxynitrite--altered platelet mitochondria--a new link between inflammation and hemostasis.
    Misztal T; Przesław K; Rusak T; Tomasiak M
    Thromb Res; 2013 Jan; 131(1):e17-25. PubMed ID: 23200902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on pig blood platelet responses to peroxynitrite action.
    Nowak P; Wachowicz B
    Platelets; 2001 Sep; 12(6):376-81. PubMed ID: 11672476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion.
    Cardoso MH; Morganti RP; Lilla S; Murad F; De Nucci G; Antunes E; Marcondes S
    Eur J Pharmacol; 2010 Feb; 627(1-3):229-34. PubMed ID: 19895807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite.
    Brown AS; Moro MA; Masse JM; Cramer EM; Radomski M; Darley-Usmar V
    Cardiovasc Res; 1998 Nov; 40(2):380-8. PubMed ID: 9893732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant and antiaggregatory effects of an extract from Conyza canadensis on blood platelets in vitro.
    Olas B; Saluk-Juszczak J; Pawlaczyk I; Nowak P; Kolodziejczyk J; Gancarz R; Wachowicz B
    Platelets; 2006 Sep; 17(6):354-60. PubMed ID: 16973495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of peroxynitrite on pig platelet lipid peroxidation and the secretory process induced by thrombin.
    Nowak P; Wachowicz B
    Cytobios; 2001; 106 Suppl 2():179-87. PubMed ID: 11545445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of brain mitochondrial Lon protease by peroxynitrite precedes electron transport chain dysfunction.
    Stanyer L; Jorgensen W; Hori O; Clark JB; Heales SJ
    Neurochem Int; 2008 Sep; 53(3-4):95-101. PubMed ID: 18598728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet aggregation by 1-methyl-4-phenyl pyridinium ion (MPP+) through ATP depletion: Evidence for the reduced platelet activities in Parkinson's disease.
    Lim KM; Kim HH; Bae ON; Noh JY; Kim KY; Kim SH; Chung SM; Shin S; Kim HY; Chung JH
    Platelets; 2009 May; 20(3):163-70. PubMed ID: 19437333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy production and utilization by human platelets in the presence of some guanidines and phenols (uremic toxins) that inhibit aggregation.
    Carroll HJ
    Thromb Diath Haemorrh; 1975 Sep; 34(1):63-71. PubMed ID: 1188836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a potent cyclooxygenase inhibitor, 5-ethyl-4-methoxy-2-phenylquinoline (KTC-5), on human platelets.
    Liao CH; Liao CH; Chang YL; Guh JH; Kuo SC; Huang LJ; Teng CM
    J Pharm Pharmacol; 2002 Jul; 54(7):967-74. PubMed ID: 12162716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
    Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of D-glucaro-1,4-lactone against oxidative modifications in blood platelets.
    Saluk-Juszczak J; Olas B; Nowak P; Staroń A; Wachowicz B
    Nutr Metab Cardiovasc Dis; 2008 Jul; 18(6):422-8. PubMed ID: 17933501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxynitrite-induced changes of thiol groups in human blood platelets.
    Nowak P; Olas B; Bald E; Głowacki R; Wachowicz B
    Platelets; 2003 Sep; 14(6):375-9. PubMed ID: 14602551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired energy metabolism in platelets from patients with Wiskott-Aldrich syndrome.
    Verhoeven AJ; van Oostrum IE; van Haarlem H; Akkerman JW
    Thromb Haemost; 1989 Feb; 61(1):10-4. PubMed ID: 2749583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid stimulation of platelets rapidly induces Ca2+-dependent dephosphorylation of cofilin that is independent of dense granule secretion and aggregation.
    Pandey D; Goyal P; Siess W
    Blood Cells Mol Dis; 2007; 38(3):269-79. PubMed ID: 17321765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.